eMedicine Specialties > Neurology > Neurological Infections

Varicella Zoster

Author: Wayne E Anderson, DO, Assistant Professor of Internal Medicine/Neurology, Western University of Health Sciences; Assistant Professor of Family Medicine, Touro University College of Osteopathic Medicine; Consulting Staff in Pain Management, Department of Neurology, California Pacific Medical Center
Contributor Information and Disclosures

Updated: Aug 30, 2007

Introduction

Background

Herpes zoster presents in many ways. It should not be considered simply a self-limited dermatomal rash with pain. Varicella-zoster virus (VZV) infection is an acute neurologic disease that warrants immediate evaluation. A common misperception is that VZV always is a benign disorder.

Following initial infection, usually as chickenpox in childhood, VZV remains dormant in the dorsal spinal root ganglion neurons and the fifth cranial nerve ganglion neurons. Upon reactivation, a spectrum of signs and symptoms can occur, including a self-limited painful rash, pain without skin manifestations, keratitis, vertigo, and spinal cord disease with weakness. Once VZV infection resolves, many individuals continue to suffer pain, a condition known as postherpetic neuralgia (PHN).

Pathophysiology

VZV remains latent in the dorsal root ganglia after an initial infection (chickenpox). Host immunologic mechanisms suppress replication of the virus, but VZV reactivates when the host mechanisms fail to contain the virus. This occurs from a wide spectrum of issues, from stress to severe immunosuppression. Occasionally this follows direct trauma. VZV viremia occurs frequently with chickenpox but also may occur with herpes zoster, albeit with a lower viral load. The virus migrates from the sensory root and produces a dermatomal sensory loss and a characteristic painful rash.

Inflammatory involvement may include the leptomeninges. When the cervical and lumbar roots are involved, motor involvement (which often is overlooked) may be seen, depending on the virulence and/or extent of migration.

VZV is a DNA virus. The viral genome encodes approximately 70 proteins. Once activated at the spinal root or cranial nerve neurons, an inflammatory response occurs that also encompasses the leptomeninges. Both plasma cells and lymphocytes are noted. In at least one case of motor neuron involvement, lymphocytic infiltration and myelin breakdown were observed with preservation of axons.

Frequency

United States

Incidence is approximately 5 per 1000 per year. Immunosuppression increases risk. The incidence of PHN increases with age. Half of patients older than 60 years may have a temporary or prolonged pain syndrome. Although 50% or more of patients with PHN may have resolution of the pain within 1-2 years, the remainder may have a continuing pain syndrome. Fortunately newer treatments are available for PHN. 

Although the frequency of varicella zoster may decrease as the vaccinated children grow to adulthood, the present frequency of varicella zoster in adults may be increasing.

International

The international frequency is the same as for the United States.

Mortality/Morbidity

Ninety-five percent of patients with zoster experience severe pain. The acute pain and insomnia are most bothersome.

  • Variant presentations of zoster (eg, keratitis, myelitis) may carry additional morbidity.
  • Duration of symptoms, incidence of complications and duration of post-herpetic neuralgia if it should occur, are longer in immunocompromised patients.
  • Complications may occur. For example, staphylococcal and streptococcal bacteria may superinfect the skin lesions and require treatment.

Race

Although the pathophysiology is uncertain, the vesicular eruption may be less frequent in African Americans. The reason is not clear.

Sex

  • Prevalence in males and females is equal.
  • Ertunc and colleagues suggested both that zoster frequency is higher in right-handed patients and that the rash appears more frequently on the left side in females.1 The pathophysiology for these differences is uncertain.

Age

  • Although zoster can occur at any age after primary infection, incidence increases with age. Also troublesome is the increasing incidence of PHN with advancing age.

Clinical

History

During the prodromal phase, paresthesias and pain may present a diagnostic dilemma; however, the dermatomal distribution helps clarify the diagnosis.

  • Goh and Khoo studied 164 patients with zoster and recorded the frequency of prodromal symptoms: 41% had pain (more common in patients older than 50 years), 27% had itching, and 12% had paresthesias.2
  • Once the typical rash erupts, the diagnosis is easier, but zoster has various presentations. Goh and Khoo reported the frequency of active disease symptoms: 90% had pain, 20% had feelings of helplessness and depression, and 12% had flu-like symptoms.2
  • Zoster may have atypical presentations. Cases of unilateral headache, the appearance of an ocular chemical burn, and facial palsy have been reported in the literature.

Physical

  • Shingles
    • Shingles refers to the painful rash associated with reactivated VZV infection; it typically affects a single dermatome, most commonly a thoracic dermatome. After a prodromal illness, erythematous macules and papules appear and progress to vesicles within 1 day. The lesions eventually crust and resolve. Patients may experience pain and sensory loss in the distribution of the rash. Motor weakness, especially in lumbar and cervical radicular distributions, is often present but not appreciated and represents viral activity beyond the sensory root. Because the weakness often is not diagnosed accurately, the incidence and prevalence are uncertain.
    • Note that zoster may present in multiple dermatomes and possibly bilaterally (ie, zoster multiplex). The frequency of multiple, disseminated, and visceral zoster is increased in the immunocompromised population. Occasionally, patients experience paresthesias and pain in a dermatomal distribution without a rash (ie, zoster sine herpete).
  • Zoster multiplex
    • Zoster occurring in noncontiguous dermatomes is rare, even in immunocompromised individuals. Terminology depends on whether the condition is unilateral or bilateral and on the number of involved dermatomes.
    • For example, zoster duplex unilateralis refers to the involvement of 2 unilateral dermatomes. Vu and colleagues report one case of zoster multiplex involving 7 noncontiguous dermatomes.
  • Myelitis and encephalitis
    • Be aware of possible VZV myelitis. Devinski and colleagues report spinal cord involvement in immunosuppressed persons.3 The condition emerges as the expected dermatomal rash.
    • Spinal cord involvement becomes apparent within 2-3 weeks from the initial rash with myelopathic findings on examination. Manifestations are usually bilateral. The disease may progress for 3 weeks, although a few cases of progression for as long as 6 months have been reported in patients with AIDS. Recurrent zoster myelitis is rare, although one case has been reported of a previously healthy young woman who developed recurrent myelopathy at the same spinal level. The condition resolved fully with intravenous (IV) acyclovir treatment.
    • Rarely, VZV may cause encephalitis. Westenend and Hoppenbrouwers reported fatal hemorrhagic encephalitis in an otherwise healthy woman.4
    • Myelitis and encephalitis may occur in previously healthy individuals.
  • Ramsay-Hunt syndrome
    • If the geniculate ganglion is involved, this syndrome of peripheral facial palsy with pain and vesicles in the ear may occur.
    • The vesicles are noted in the external ear canal or on the tympanic membrane; additional auditory and vestibular symptoms may be present.
  • Keratitis
    • Ocular involvement occurs when the ophthalmic division of the trigeminal nerve is involved in the viral reactivation (see Media file 1).
    • Complications range from corneal ulcers to conjunctivitis to blindness.
    • Occasionally, no vesicles are seen (ie, zoster sine herpete).
    • Svozilkova and colleagues report one case of varicella-caused retinal necrosis after ocular trauma.5
  • Zoster sine herpete
    • VZV reactivation may occur without cutaneous vesicles. In such cases, patients may experience pain and weakness in a dermatomal distribution but have no visible signs of shingles.
    • Furuta and coworkers noted that VZV may be demonstrated in 8-25% of patients with acute peripheral facial palsy without cutaneous vesicles.6
    • This condition presents a diagnostic dilemma; however, VZV DNA may be detected by polymerase chain reaction (PCR) from oropharyngeal swabs in patients with zoster peripheral facial palsy. Because such studies are not routine, the true incidence and prevalence are unknown.
  • Brachial plexus neuritis
    • Fabian and colleagues reported one patient who had a left upper arm monoplegia after a C4, C5, and C6 zoster multiplex.
    • The authors believed that the brachial plexus inflammation was an extension of a dorsal ganglionitis. They found that the motor neuropathy was an inflammatory demyelinating process.

Causes

Risk of typical shingles and atypical presentations (eg, myelitis, encephalitis, disseminated disease, visceral involvement) is increased in immunosuppressed patients.

More on Varicella Zoster

Overview: Varicella Zoster
Differential Diagnoses & Workup: Varicella Zoster
Treatment & Medication: Varicella Zoster
Follow-up: Varicella Zoster
Multimedia: Varicella Zoster
References

References

  1. Ertunc V, Dane S, Karakuzu A, Deniz O. Higher herpes zoster infection frequency in right-handed patients and more frequent appearance in the left body side of females. Acta Derm Venereol. May 1997;77(3):245. [Medline].

  2. Goh CL, Khoo L. A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic. Int J Dermatol. Sep 1997;36(9):667-72. [Medline].

  3. Devinsky O, Cho ES, Petito CK, Price RW. Herpes zoster myelitis. Brain. Jun 1991;114 ( Pt 3):1181-96. [Medline].

  4. Westenend PJ, Hoppenbrouwers WJ. [Fatal varicella-zoster encephalitis; a rare complication of herpes zoster]. Ned Tijdschr Geneeskd. Mar 21 1998;142(12):654-7. [Medline].

  5. Svozilkova P, Rihova E, Diblik P, et al. Varicella zoster virus acute retinal necrosis following eye contusion: case report. Virol J. Aug 31 2005;2:77. [Medline].

  6. Furuta Y, Fukuda S, Suzuki S, et al. Detection of varicella-zoster virus DNA in patients with acute peripheral facial palsy by the polymerase chain reaction, and its use for early diagnosis of zoster sine herpete. J Med Virol. Jul 1997;52(3):316-9. [Medline].

  7. Stein GE. Pharmacology of new antiherpes agents: famciclovir and valacyclovir. J Am Pharm Assoc (Wash). Mar-Apr 1997;NS37(2):157-63. [Medline].

  8. Kubeyinje EP. Cost-benefit of oral acyclovir in the treatment of herpes zoster. Int J Dermatol. Jun 1997;36(6):457-9. [Medline].

  9. Morgan R, King D. Characteristics of patients with shingles admitted to a district general hospital. Postgrad Med J. Feb 1998;74(868):101-3. [Medline].

  10. Galil K, Choo PW, Donahue JG, Platt R. The sequelae of herpes zoster. Arch Intern Med. Jun 9 1997;157(11):1209-13. [Medline].

  11. Hong JJ, Elgart ML. Gastrointestinal complications of dermatomal herpes zoster successfully treated with famciclovir and lactulose. J Am Acad Dermatol. Feb 1998;38(2 Pt 1):279-80. [Medline].

  12. Rowbotham MC, Fields HL. The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia. Brain. Apr 1996;119 (Pt 2):347-54. [Medline].

  13. Rowbotham MC, Davies PS, Verkempinck C, Galer BS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain. Apr 1996;65(1):39-44. [Medline].

  14. Oaklander AL, Romans K, Horasek S, et al. Unilateral postherpetic neuralgia is associated with bilateral sensory neuron damage. Ann Neurol. Nov 1998;44(5):789-95. [Medline].

  15. Gilden DH, Cohrs RJ, Mahalingam R. VZV vasculopathy and postherpetic neuralgia: progress and perspective on antiviral therapy. Neurology. Jan 11 2005;64(1):21-5. [Medline].

  16. Baik JS, Kim WC, Heo JH, Zheng HY. Recurrent herpes zoster myelitis. J Korean Med Sci. Aug 1997;12(4):360-3. [Medline].

  17. Carreau JP, Gola R, Cheynet F, Guyot L. [Zona of the cranial nerves. Current aspects]. Rev Stomatol Chir Maxillofac. Oct 1998;99(3):155-64. [Medline].

  18. Cohen JI. Varicella-zoster virus. The virus. Infect Dis Clin North Am. Sep 1996;10(3):457-68. [Medline].

  19. Cohen JI, Brunell PA, Straus SE, Krause PR. Recent advances in varicella-zoster virus infection. Ann Intern Med. Jun 1 1999;130(11):922-32. [Medline].

  20. Fabian VA, Wood B, Crowley P, Kakulas BA. Herpes zoster brachial plexus neuritis. Clin Neuropathol. Mar-Apr 1997;16(2):61-4. [Medline].

  21. Feder HM, LaRussa P, Steinberg S, Gershon AA. Clinical varicella following varicella vaccination: don''t be fooled. Pediatrics. Jun 1997;99(6):897-9. [Medline].

  22. Goldman GS. Universal varicella vaccination: efficacy trends and effect on herpes zoster. Int J Toxicol. Jul-Aug 2005;24(4):205-13. [Medline].

  23. Liang MG, Heidelberg KA, Jacobson RM, McEvoy MT. Herpes zoster after varicella immunization. J Am Acad Dermatol. May 1998;38(5 Pt 1):761-3. [Medline].

  24. Mainka C, Fuss B, Geiger H, et al. Characterization of viremia at different stages of varicella-zoster virus infection. J Med Virol. Sep 1998;56(1):91-8. [Medline].

  25. Makeham TP, Croxson GR, Coulson S. Infective causes of facial nerve paralysis. Otol Neurotol. Jan 2007;28(1):100-3. [Medline].

  26. Sawyer AR, Williams G. Misdiagnosis of burns: herpes zoster ophthalmicus. J Burn Care Res. Nov-Dec 2006;27(6):914-6. [Medline].

  27. Sjaastad O, Bakketeig LS. The rare, unilateral headaches. VÃ¥gÃ¥ study of headache epidemiology. J Headache Pain. Jan 15 2007;[Medline].

  28. Sparks L, Russell C. The new varicella vaccine: efficacy, safety, and administration. J Pediatr Nurs. Apr 1998;13(2):85-94. [Medline].

  29. Vu AQ, Radonich MA, Heald PW. Herpes zoster in seven disparate dermatomes (zoster multiplex): report of a case and review of the literature. J Am Acad Dermatol. May 1999;40(5 Pt 2):868-9. [Medline].

  30. Wlodaver CG, Privett T, Livengood G. The merits of varicella vaccination for varicella non-immune health care workers. J Okla State Med Assoc. Dec 1996;89(12):430-2. [Medline].

  31. Yi JY, Kim TY, Shim JH, et al. Histopathological findings, viral DNA distribution and lymphocytic immunophenotypes in vesicular and papular types of herpes zoster. Acta Derm Venereol. May 1997;77(3):194-7. [Medline].

Further Reading

Keywords

varicella-zoster, VSV, varicella-zoster virus, VZV infection, chickenpox, chicken pox, herpes zoster, shingles, Ramsay-Hunt syndrome, zoster multiplex, zoster sine herpete, keratitis, postherpetic neuralgia, PHN, varicella zoster

Contributor Information and Disclosures

Author

Wayne E Anderson, DO, Assistant Professor of Internal Medicine/Neurology, Western University of Health Sciences; Assistant Professor of Family Medicine, Touro University College of Osteopathic Medicine; Consulting Staff in Pain Management, Department of Neurology, California Pacific Medical Center
Wayne E Anderson, DO is a member of the following medical societies: American Academy of Neurology, American Medical Association, American Society of Law Medicine and Ethics, California Medical Association, and San Francisco Medical Society
Disclosure: Cephalon Honoraria Speaking and teaching; Endo Honoraria Speaking and teaching; King Honoraria Consulting; Alpharma Honoraria Speaking and teaching

Medical Editor

J Stephen Huff, MD, Associate Professor, Emergency Medicine and Neurology, Department of Emergency Medicine, University of Virginia Health Sciences Center
J Stephen Huff, MD is a member of the following medical societies: American Academy of Emergency Medicine, American Academy of Neurology, American College of Emergency Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Florian P Thomas, MD, MA, PhD, Drmed, Director, Spinal Cord Injury Unit, St Louis Veterans Affairs Medical Center; Director, National MS Society Multiple Sclerosis Center; Professor, Department of Neurology and Psychiatry, Associate Professor, Institute for Molecular Virology, and Department of Molecular Microbiology and Immunology, St Louis University
Florian P Thomas, MD, MA, PhD, Drmed is a member of the following medical societies: American Academy of Neurology, American Paraplegia Society, and National Multiple Sclerosis Society
Disclosure: Nothing to disclose.

CME Editor

Matthew J Baker, MD, Consulting Staff, Collier Neurologic Specialists, Naples Community Hospital
Matthew J Baker, MD is a member of the following medical societies: American Academy of Neurology
Disclosure: Nothing to disclose.

Chief Editor

Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants
Nicholas Y Lorenzo, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Neurology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.